All News #Library
Biotech
Immunoforge Hosts Partnering Meetings At J.P. Morgan Health Conf
01 Jan 2026 //
PR NEWSWIRE
ImmunoForge`s IND Approval For Pemziviptadil Ph 2 Trial & KF1601 Ph 1
14 Jan 2025 //
PR NEWSWIRE
ImmunoForge Doses First Patient in Phase 2 Clinical Trial of Froniglutide
17 Oct 2023 //
PR NEWSWIRE
ImmunoForge Expands Drug Development Licensing Agreement with Duke University
18 May 2023 //
PR NEWSWIRE

Market Place
Sourcing Support